Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) 2021 annual work report of the board of supervisors
Wanbangde Pharmaceutical Holding Group Co.Ltd(002082)
Work report of the board of supervisors in 2021
In 2021, all members of the board of supervisors of Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) (hereinafter referred to as the "company") exercised their duties diligently and independently in accordance with the provisions of the company law of the people's Republic of China (hereinafter referred to as the "company law"), the securities law of the people's Republic of China (hereinafter referred to as the "Securities Law") and other laws and regulations, as well as the requirements of the articles of association and the rules of procedure of the board of supervisors of the company, and exercised their functions and powers according to law Supervise major matters such as related party transactions, foreign investment and financial status, as well as the daily performance of directors and senior managers, so as to promote the standardized operation of the company. The report on the performance of the board of supervisors in 2021 is as follows:
1、 Work of the board of supervisors
Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) the board of supervisors earnestly performs the function of supervision and supervision in accordance with the company law, the articles of association and other relevant provisions. During the reporting period, the supervisors of the company attended the 2020 annual general meeting of shareholders of the company, attended all meetings of the board of directors as nonvoting delegates, deliberated and supervised the proposals and procedures of the previous board of directors and general meetings of shareholders, and held 8 meetings of the board of supervisors. The details are as follows:
Meeting name, meeting time and proposal deliberated at the meeting
1. Proposal on 2021.1.10 of the sixth meeting on Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) the report on the sale of major assets and related party transactions of the 8th board of supervisors (Draft) (Revised Version) and its summary;
2. Proposal on adding related party guarantees and related party transactions after the sale of major assets of the company.
The 8th board of supervisors 2021.2.3 1 Proposal on change of accounting firm.
Seventh meeting
The 8th board of supervisors 1 Proposal on share repurchase plan of the company;
The 8th meeting 2021.3.14 2 Proposal on the implementation of the "Black Economic Revitalization Act" by the South African subsidiary of Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) Medical Technology Co., Ltd.
1. Work report of the board of supervisors in 2020;
2. Financial statement report of 2020;
3. 2020 profit distribution plan;
The 8th board of supervisors 4 Proposal on the provision for impairment of goodwill;
The 9th meeting May 27, 20212020 annual report and its summary;
6. Proposal on self-evaluation report of internal control in 2020; 7. Proposal on the company's 2021 annual guarantee plan;
8. Proposal on providing financial assistance to holding subsidiaries and their subsidiaries;
Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) 2021 annual work report of the board of supervisors
9. Proposal on renewing the appointment of audit institutions in 2021.
The 8th board of supervisors on April 28, 2021 Full text and text of the first quarter report of 2021;
10th meeting 2 Proposal on using self owned idle funds to purchase financial products.
The 8th board of supervisors may 26, 2021 Proposal on signing house lease agreement and related party transactions.
Eleventh meeting
The 8th board of supervisors on August 25, 2021 Semi annual report of 2021 and its summary.
Twelfth Meeting
The 8th board of supervisors October 26, 2021 Third quarter report 2021.
Thirteenth meeting
2、 Verification opinions of the board of supervisors on relevant matters of the company in 2021
1. Legal operation of the company
During the reporting period, the board of supervisors supervised the convening procedures and resolutions of the general meeting of shareholders and the board of directors, the implementation of the resolutions of the general meeting of shareholders by the board of directors, the performance of the duties of the company's senior managers and the implementation of the company's management system in accordance with relevant national laws and regulations. Considering that the board of directors of the company can operate in accordance with the company law, the securities law, the articles of association and other laws and regulations, strictly implement the resolutions and authorizations of the general meeting of shareholders, the decision-making procedures are legal, scientific and democratic, and strictly abide by the company law, the Securities Law and other laws and regulations, as well as the provisions made by the CSRC and the articles of association, A relatively perfect internal control system has been established and is constantly improving. Timely and accurate information disclosure. The directors and other senior managers of the company can be loyal to their duties and standardize management, and there is no violation of national laws, regulations, articles of association or any behavior damaging the interests of the company and shareholders' rights and interests; In 2021, there was no illegal occupation of the company's funds by related parties of the company, and there was no occupation of funds by related parties in previous years and accumulated to December 31, 2021.
2. Check the relevant financial situation of the company
The board of supervisors has effectively supervised, inspected and reviewed the company's financial system, financial management, financial status and financial results, and believes that the company has sound financial system, standardized financial operation and good financial status. The 2021 annual financial report can truly reflect the company's financial situation and operating results. The standard unqualified opinion Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) 2021 annual financial audit report issued by Dahua Certified Public Accountants (special general partnership) is true, objective and fair.
3. Review the internal control of the company
Opinions of the board of directors on the self-evaluation report of the company's internal control in 2021 and the company's internal control system
Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) 2021 annual work report of the board of supervisors
After reviewing the construction and operation, it is considered that the company has established a relatively perfect internal control system and can be effectively implemented.
The self-evaluation report of the company's internal control truly and objectively reflects the construction and operation of the company's internal control system.
4. External guarantee, equity and asset replacement
During the reporting period, due to the needs of the operation and development of wholly-owned subsidiaries, the company provided joint and several liability guarantees for some wholly-owned subsidiaries, and the guarantee items fulfilled the obligations of examination and approval and information disclosure in accordance with the stock listing rules of Shenzhen Stock Exchange, the articles of association and other normative documents; There was no equity or asset replacement during the reporting period. In 2022, the board of supervisors will actively adapt to the development needs of the company, expand work ideas, abide by the principle of good faith, strengthen supervision, take it as its own responsibility to effectively safeguard and protect the interests of the company and shareholders, faithfully and diligently perform its supervision duties, and do a solid job in all work, so as to promote the better and faster development of the company.
Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) board of supervisors
April 13, 2002
